Literature DB >> 17654147

The effect of dosing vehicle on arsenic bioaccessibility in smelter-contaminated soils.

Nicholas T Basta1, Jill N Foster, E A Dayton, Robin R Rodriguez, Stan W Casteel.   

Abstract

In vitro gastrointestinal (IVG) methods have been developed to provide an expedient and inexpensive means to estimate bioavailability of arsenic and other contaminants from ingestion of contaminated soil. Both in vivo and in vitro techniques have used a fasting model when determining Pb bioavailability/bioaccessibility as a conservative estimate of risk. Some IVG procedures have incorporated a dosing vehicle (DV) or food (i.e., milk) to simulate in vivo conditions. Potential differences in the bioaccessibility of contaminants between fasting and fed states remain a concern for those interested in adopting in vitro procedures for regulatory purposes. In this study, the effect of eliminating a dough-like DV on As bioaccessibility (BA), and this effect on the relationship between in vitro bioaccessible and in vivo relative bioavailability (RBA) As is determined. Also, the effect of phosphate from the DV on IVG BA is investigated. Two types of smelter-contaminated soils, calcine and iron slag, were used to examine the effect of dosing vehicle (DV) on BA determined by IVG. Dosing vehicle did not affect BA in the gastric extraction (GE) or intestinal extraction (IE) for 3 of the 5 calcinated contaminated soils. Inclusion of DV in the GE slightly increased BA for 2 of the 5 slag-contaminated soils. Increases in BA from DV may be attributed to ligand exchange of arsenate with phosphate. Strong relationships between BA and in vivo RBA As were found with or without DV. Bioaccessible As measured by the GE was strongly correlated with in vivo RBA As (IVG without DV: r=0.92, P<0.01; IVG with DV: r=0.96; P<0.01). Similarly, BA measured by the IE was strongly correlated with in vivo RBA As (IVG without DV: r=0.90, P<0.01; IVG with DV: r=0.96, P<0.01). The IVG method, with or without DV, is a reliable method to use as a rapid screening tool to provide an estimate of BA in contaminated soils. Further studies should be conducted to determine the influence of foodstuffs on BA for different types of As contaminated soil (i.e., non-smelter soil).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17654147     DOI: 10.1080/10934520701434927

Source DB:  PubMed          Journal:  J Environ Sci Health A Tox Hazard Subst Environ Eng        ISSN: 1093-4529            Impact factor:   2.269


  6 in total

Review 1.  Assessing the bioavailability and bioaccessibility of metals and metalloids.

Authors:  Jack C Ng; Albert Juhasz; Euan Smith; Ravi Naidu
Journal:  Environ Sci Pollut Res Int       Date:  2013-06-14       Impact factor: 4.223

2.  Bioaccessibility of lead and arsenic in traditional Indian medicines.

Authors:  Iris Koch; Maeve Moriarty; Kim House; Jie Sui; William R Cullen; Robert B Saper; Kenneth J Reimer
Journal:  Sci Total Environ       Date:  2011-08-23       Impact factor: 7.963

3.  Modification of an existing in vitro method to predict relative bioavailable arsenic in soils.

Authors:  Shane Whitacre; Nicholas Basta; Brooke Stevens; Valerie Hanley; Richard Anderson; Kirk Scheckel
Journal:  Chemosphere       Date:  2017-04-03       Impact factor: 7.086

4.  Effect of biogeochemical interactions on bioaccessibility of arsenic in soils of a former smelter site in Republic of Korea.

Authors:  Kyung Yang; Seulki Jeong; Eun Hea Jho; Kyoungphile Nam
Journal:  Environ Geochem Health       Date:  2016-01-14       Impact factor: 4.609

5.  Relative bioavailability and bioaccessibility and speciation of arsenic in contaminated soils.

Authors:  Karen D Bradham; Kirk G Scheckel; Clay M Nelson; Paul E Seales; Grace E Lee; Michael F Hughes; Bradley W Miller; Aaron Yeow; Thomas Gilmore; Sophia M Serda; Sharon Harper; David J Thomas
Journal:  Environ Health Perspect       Date:  2011-07-13       Impact factor: 9.031

Review 6.  In vivo and in vitro methods for evaluating soil arsenic bioavailability: relevant to human health risk assessment.

Authors:  Karen D Bradham; Gary L Diamond; Michele Burgess; Albert Juhasz; Julie M Klotzbach; Mark Maddaloni; Clay Nelson; Kirk Scheckel; Sophia M Serda; Marc Stifelman; David J Thomas
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2018       Impact factor: 8.071

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.